BPG is committed to discovery and dissemination of knowledge
Case Report
Copyright: ©Author(s) 2026.
World J Gastrointest Pharmacol Ther. Sep 5, 2026; 17(3): 120771
Published online Sep 5, 2026. doi: 10.4292/wjgpt.120771
Figure 3
Figure 3 Colonoscopy findings in case 2 on maintenance therapy with ustekinumab every 4 weeks and tofacitinib 5 mg twice daily - two years into deep remission. Scarred mucosa, Mayo endoscopic score 0. A: Transverse colon; B: Sigmoid colon.


Write to the Help Desk